Prieto VA

Language: Spanish
References: 29
Page: 23-35
PDF size: 251.26 Kb.

ABSTRACT

Introductions: To assess the endovascular treatment (simple or stent angioplasty) of the obliterating injuries of aortoiliac sector for two years to related the results to permeability. Methods: Thirty patients admitted in the Arteriology service of the CIMEQ Hospital diagnosed with atherosclerosis obliterans. The different endovascular procedures applied in repair of aortoiliac sector injuries, the type of technique used and the selective use of stent according the international criteria are described. Trasatlantic consensus classification (Type A, B, and C) was applied in angiography studies. Accumulative permeability was determined relating it to results. Atherosclerotic risk factors were taken into account. Results: There was not any complication in the 63,3 % patients operated on, but in the remainder cases it was related to the puncture site. The accumulative permeability of procedures carried out was of 98,0 at 6 months; of 84,0 at 12 months and of 68,5 % at 20 months. In type A injuries at a year it was noted a accumulative permeability of 89,0% and at two years it was of 87,0 %. In the case of the type B, the above mentioned permeability was of 93,0 % and of 75,0 % at 1 year and of 44,0 % at 2 years. Considering the group as a whole, this permeability was of 58,0 % at 12 months and of 44,0 % at 24 months. Conclusions: The use of endovascular techniques is reliable. The results of its permeability are influenced by severity of treated injuries with a greater permeability in the types A and B (Trasatlantic consensus classification).

REFERENCES

1. Baker JD. Physiologic studies to document severity of aortoiliac occlusive. Curr Therap in Vasc Surg.2001;10(2):45-9.

2. Brewster DC. Current controversies in the management of aortoiliac occlusive disease. J Vasc Surg. 1997;25(2):365-79.

3. Blaisdell FW, Hall AD. Axillary femoral bypass for lower extremity ischemia. Surgery. 1963;54:563-71.

4. Donaldson MC, Louras JC, Bucknam CA. Axillofemoral bypass: a tool with a limited role. J Vasc Surg. 1986;3(5):757-63.

5. Parodi JC. The EVAR revolution. Endovasc Today. 2004;10:51-4.

6. Dormandy JA, Rutherford RB. Management of peripheral arterial disease. TransAtlantic Inter-Society Consensus. J Vasc Surg. 2000;31(1):1-6.

7. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR. Inter-society consensus for the management of peripheral arterial disease TASC II. Eur J Endovasc Surg. 2007;33:1-75.

8. ACC/AHA. Practice guidelines for the management of patients UIT peripheral arterial disease. Circulation. 2006;113:1474-84.

9. Schneider PA. Endovascular or open surgery for aortoiliac occlusive disease? Cardiovasc Surg. 2002;10(4):378-82.

10. Vaquero C. Angiología y cirugía vascular en el momento actual. Rev Clin Esp. 2005;54:2-5.

11. Bell P. What's new in vascular and endovascular surgery. J Cardiovasc Surg. 2005;46(4):323-6.

12. Fred A, Douglas B, Haimesh S. Current guidelines produce competent endovascular surgeon. J Vasc Surg. 2006;43:992-8.

13. Kent KC, Moscucci M, Mansour KA, Dimattia S, Gallagher S, Kuntz R, et al. Retroperitoneal hematoma after cardiac catheterization: prevalence, risk factors and optimal management. J Vasc Surg. 1994;20:905-13.

14. Cadman PJ. Case report: femoral nerve palsy complicating femoral artery puncture and intra-arterial thrombolysis. Clin Radiol. 1995;50:345-6.

15. Briony JB, Andrtea JP. The timing and frecuency of complications after peripheral percutaneus transluminal angioplasty and iliac stenting: Is a change from inpatient to outpatient therapy feasible? Cardiovasc Intervent Radiol. 2000;23:452-6.

16. Whaitling PJ, Gibson M. Iliac occlusions: stenting or crossover grafting? An examination of patency and cost. Eur J Vasc Endovasc. 2000;20:36-40.

17. Rosset E, Malikov S. Endovascular treatment of occlusive desease in the distal aorta: Mid-term result in a series of 31 consecutive patients. Ann Vasc Surg. 2001;15:140-7.

18. Karch LA. Clinical failure after percutaneous transluminal angioplasty of the superficial femoral and popliteal arteries. J Vasc Surg. 2000;13:880-8.

19. Carnevale FC, de Blas M, Merino S, Egaña JM. Percutaneous endovascular treatment of chronic iliac artery occlusion. Cardiovasc Intervent Radiol. 2004;27:447-52.

20. Berguer T, Sorensen R, Honrad J. Aortic rupture: a complication of transluminal angioplasty. Am J Roentgenol. 1986;146:373-4.

21. Allaire E, Melliere D. Iliac artery rupture during balloon dilatation: What treatment? Ann Vasc Surg. 2003;17:306-14.

22. Carey D, Martin JR, Moore CA, Valentine MC, Nygaard TW. Complications of femoral artery closure devices. Catheteriz Cardiovasc Interv. 2001;52:3-7.

23. Corthéoux P, Theron J, Alachkar F. L´angioplastie endoluminale percutanee dans le traitement des sténoses athéromatuses de l áorte abdominales terminale. Ann Radiol. 1987;30:37-41.

24. Diethrich EB, Santiago O, Gustafson G. Preliminary Observations on the use of the Palmaz stent in the distal portion of the abdominal aorta. Am Herat J. 1993;125:490-500.

25. Galaria I, Mark D. Percutaneos Transluminal Revascularization for iliac occlusive disease: Long term outcomes in transatlantic inter-society consensus A and B lesions. Ann Vasc Surg. 2005;19:352-60.

26. Timaran H, Trent L, Scott L, Feeman B, Goldamn H. Implantación de stents arteriales ilíacos frente a reconstrucción quirúrgica para lesiones de tipo TASC B y C. J Vasc Surg. 2002;38(2):23-6.

27. Faries PL, Brophy D, Logerfo FW, Pomposelli FB. Combined iliac angioplasty and infrainguinal revascularization surgery are effective in diabetic patients with multilevel arterial disease. Ann Vasc Surg. 2001;15:67-72.

28. Maynar M, Zanders T. Bifurcated endoprosthesis for treatment of aortoiliac occlussive lesions. J Endovasc Ther. 2005;12:22-7.

29. Ballard JL, Bergan JJ, Singh P. Aortoiliac stent deployment versus surgical reconstruction: analysis of outcome and cost. J Vasc Surg. 1998;28(1):94-101.